Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $300M (Mar 2026) led by Series X Capital. Became independent corporation; Alphabet now minority investor. Partners include Samsung Galaxy Watch 8 and Salesforce.
Verily is a precision health AI company that became independent from Alphabet (Google's parent) in March 2026 when it raised $300 million led by Series X Capital, transitioning Alphabet to a minority investor. The independence marks a major strategic inflection: Verily now competes as a standalone health AI platform rather than operating as a Google moonshot project, with the commercial accountability that comes with external capital and institutional investors.
Benchling is a life sciences R&D cloud platform with ~$200M+ ARR. Series E startup valued at ~$6.1B. Trusted by Pfizer, Genentech, and 1,000+ biotech/pharma teams. HQ: San Francisco.
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The company offers an integrated suite of tools including electronic lab notebooks (ELN), laboratory information management systems (LIMS), molecular biology design tools, and data management platforms, all connected in a unified cloud environment.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.